Teleflex to Present at the 40th Annual Goldman Sachs Global Healthcare Conference

NEXT STORY
CRISPR Therapeutics to Present at Upcoming Investor Conferences
PREV STORY
U.S. FDA Grants Priority Review for Vascepa® (Icosapent Ethyl) Supplemental New Drug Application Seeking Cardiovascular Risk Reduction Indication
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease

author_avatar
NASDAQ Market News

Immune Design Announces Launch of Web Portal for SYNOVATE Phase 3 Study of CMB305 Immunotherapy in Synovial Sarcoma

          -- 1st global Phase 3 trial focused on synovial ...

author_avatar
NASDAQ Market News

Worldwide Medication Management System Industry to 2025 – Clinical Decision Support System Solutions Segment to Hold a Major Market Share

author_avatar
NASDAQ Market News